Eilon Kirson

2018

In 2018, Eilon Kirson earned a total compensation of $3.1M as Chief Science Officer and Head of at NovoCure, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$286,340
Option Awards$1,769,541
Salary$461,783
Stock Awards$440,618
Other$184,522
Total$3,142,804

Kirson received $1.8M in option awards, accounting for 56% of the total pay in 2018.

Kirson also received $286.3K in non-equity incentive plan, $461.8K in salary, $440.6K in stock awards and $184.5K in other compensation.

Rankings

In 2018, Eilon Kirson's compensation ranked 3,673rd out of 14,244 executives tracked by ExecPay. In other words, Kirson earned more than 74.2% of executives.

ClassificationRankingPercentile
All
3,673
out of 14,244
74th
Division
Manufacturing
1,361
out of 5,759
76th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
168
out of 849
80th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
93
out of 547
83rd
Industry
Surgical and Medical Instruments and Apparatus
59
out of 348
83rd
Source: SEC filing on April 10, 2019.

Kirson's colleagues

We found five more compensation records of executives who worked with Eilon Kirson at NovoCure in 2018.

2018

Asaf Danziger

NovoCure

Chief Executive Officer

2018

William Doyle

NovoCure

Chairman

2018

Wilhelmus Groenhuysen

NovoCure

Chief Financial Officer

2018

Pritesh Shah

NovoCure

Chief Commercial Officer

2018

Michael Ambrogi

NovoCure

Chief Operating Officer

News

In-depth

You may also like